DoubleBlind Issue 12

Preorder our latest psychedelic magazine. In this issue, we look at what FDA's rejection of MDMA thearpy means for the future of psychedelics. Meanwhile, we honor the indigenous stewards who continue to fight for the biocultural preservation of their ancestral ways. Through these stories, a theme of resilience emerges: Resilience on the part of psychedelic advocates who won’t be deterred by the FDA; people who are determined to heal whether or not the medical system supports them in doing so; and indigenous leaders who, after generations of exploitation and neglect, are still fighting to protect delicate ecosystems w